Authors:
NUMICO G
VANNOZZI MO
GARRONE O
BERGAGLIO M
TOLINO G
LUNARDI G
Citation: G. Numico et al., PHARMACOKINETIC (PK) STUDY OF A COMBINED PACLITAXEL (P) AND EPIDOXORUBICIN (E) REGIMEN, European journal of cancer, 34, 1998, pp. 175-175
Authors:
VIALE M
PASTRONE I
PELLECCHIA C
VANNOZZI MO
CAFAGGI S
ESPOSITO M
Citation: M. Viale et al., COMBINATION OF CISPLATIN-PROCAINE COMPLEX DPR WITH ANTICANCER DRUGS INCREASES CYTOTOXICITY AGAINST OVARIAN-CANCER CELL-LINES, Anti-cancer drugs, 9(5), 1998, pp. 457-463
Authors:
NUMICO G
BENASSO M
VANNOZZI MO
MERLANO M
ROSSO R
VIALE M
ESPOSITO M
Citation: G. Numico et al., HYDRATION REGIMEN AND HEMATOLOGICAL TOXICITY OF A CISPLATIN-BASED CHEMOTHERAPY REGIMEN - CLINICAL OBSERVATIONS AND PHARMACOKINETIC ANALYSIS, Anticancer research, 18(2B), 1998, pp. 1313-1318
Authors:
NOBILE MT
BARZACCH MC
SANGUINETI O
CHIARA S
GOZZA A
VINCENTI M
LAVARELLO A
COGNEIN P
LIONETTO R
PERCIVALE PL
BERTOGLIO S
MUROLO C
ESPOSITO M
VANNOZZI MO
ROSSO R
Citation: Mt. Nobile et al., ACTIVITY OF HIGH-DOSE 24-HOUR 5-FLUOROURACIL INFUSION PLUS L-LEUCOVORIN IN ADVANCED COLORECTAL-CANCER, Anticancer research, 18(1B), 1998, pp. 517-521
Authors:
LERZA R
VANNOZZI MO
TOLINO G
VIALE M
BOTTINO GB
BOGLIOLO G
CERRUTI A
CASTELLO G
MENCOBONI M
REGGIARDO G
PANNACCIULLI I
ESPOSITO M
Citation: R. Lerza et al., CARBOPLATIN AND CISPLATIN PHARMACOKINETICS AFTER INTRAPLEURAL COMBINATION TREATMENT IN PATIENTS WITH MALIGNANT PLEURAL EFFUSION, Annals of oncology, 8(4), 1997, pp. 385-391
Authors:
MIGLIETTA L
CANOBBIO L
GRANETTO C
VANNOZZI MO
ESPOSITO M
BOCCARDO F
Citation: L. Miglietta et al., SURAMIN EPIDOXORUBICIN ASSOCIATION IN HORMONE-REFRACTORY PROSTATE-CANCER - PRELIMINARY-RESULTS OF A PILOT PHASE-II STUDY/, Journal of cancer research and clinical oncology, 123(7), 1997, pp. 407-410
Authors:
BALLESTRERO A
FERRANDO F
GARUTI A
BASTA P
GONELLA R
ESPOSITO M
VANNOZZI MO
SORICE G
FRIEDMAN D
PUGLISI M
BREMA F
MELA GS
SESSAREGO M
PATRONE F
Citation: A. Ballestrero et al., HIGH-DOSE MITOXANTRONE WITH PERIPHERAL-BLOOD PROGENITOR-CELL RESCUE -TOXICITY, PHARMACOKINETICS AND IMPLICATIONS FOR DOSAGE AND SCHEDULE, British Journal of Cancer, 76(6), 1997, pp. 797-804
Authors:
CIVALLERI D
ESPOSITO M
DECIAN F
BALLETTO N
MONDINI G
GOGIOSO L
VIALE M
VANNOZZI MO
Citation: D. Civalleri et al., EFFECT OF HYALURONIDASE ON THE PHARMACOKINETICS OF FREE AND TOTAL PLATINUM SPECIES AFTER INTRAARTERIAL CISPLATIN IN REFRACTORY PATIENTS WITH COLORECTAL LIVER METASTASES, Clinical drug investigation, 12(2), 1996, pp. 94-104
Authors:
VANNOZZI MO
NOBILE NT
SANGUINETI O
BARZACCHI C
VIALE M
NUMICO G
ESPOSITO M
Citation: Mo. Vannozzi et al., PHARMACOKINETICS OF (6S)-LEUCOVORIN AND 5-METHYLTETRAHYDROFOLATE AFTER 4-HOUR CONTINUOUS INTRAVENOUS-INFUSION FOLLOWED BY REPEATED ORAL DOSES OF (6S)-LEUCOVORIN IN PATIENTS WITH COLORECTAL-CANCER TREATED WITH 5-FLUOROURACIL, Clinical drug investigation, 12(1), 1996, pp. 39-45
Authors:
VIALE M
VANNOZZI MO
MERLO F
CAFAGGI S
PARODI B
ESPOSITO M
Citation: M. Viale et al., CISPLATIN COMBINED WITH THE NEW CISPLATIN-PROCAINE COMPLEX DPR - IN-VITRO AND IN-VIVO STUDIES, European journal of cancer, 32A(13), 1996, pp. 2327-2333
Authors:
ESPOSITO M
VIALE M
VANNOZZI MO
ZICCA A
CADONI A
MERLO F
GOGIOSO L
Citation: M. Esposito et al., EFFECT OF THE ANTIARRHYTHMIC DRUG PROCAINAMIDE ON THE TOXICITY AND ANTITUMOR-ACTIVITY OF CIS-DIAMMINEDICHLOROPLATINUM(II), Toxicology and applied pharmacology, 140(2), 1996, pp. 370-377
Authors:
ESPOSITO M
VANNOZZI MO
VIALE M
FULCO RA
COLLECCHI P
MERLO F
DECIAN F
ZICCA A
CADONI A
POIRIER MC
Citation: M. Esposito et al., PARA-AMINOBENZOIC ACID SUPPRESSION OF CIS-DIAMMINEDICHLOROPLATINUM(II) NEPHROTOXICITY, Carcinogenesis, 14(12), 1993, pp. 2595-2599